Tag: Boston Scientific
HI-PEITHO finds catheter-based procedure improves pulmonary embolism outcomes
Patients who underwen...
First procedures performed in FRACTURE trial of Bolt IVL system in coronary artery disease
The first US procedur...
Boston Scientific to acquire renal denervation technology developer SoniVie
Boston Scientific has...
ACURATE IDE results put spotlight on impact of valve under-expansion after TAVI
“Disappointed is an u...
Medtech Insights: Trial pipeline underpins growth strategy for Watchman LAAC device
Investment in a programme...
Boston Scientific announces position on FDA update about use of paclitaxel-coated devices to treat PAD
Following yesterday's new...
ADVERTORIAL: “No stroke is innocent”: Why stroke matters for TAVI patients
This advertorial is spons...
Boston Scientific reveals CE mark for Acurate neo 2 in Q1 financial results report
Boston Scientific, ac...
Selecting the right valve for the patient is key for a successful TAVI program
NOTE: This video is ONLY ...
Boston Scientific, Edwards Lifesciences agree to global litigation settlement
Boston Scientific and Edw...
ADVERTORIAL: Unique design and features of the ACURATE neo (TM) enable safe and efficient procedures
This content is only ...
PCR LV 2018: Favourable outcomes for next-generation Acurate neo2 TAVI system
A new study evaluatin...
Short-term DAPT is feasible for patients undergoing percutaneous LAA closure
Felix Weise (Cardioan...
Boston Scientific enters into an acquisition option agreement with Millipede
Boston Scientific has...
Boston Scientific pushes back plans for commercialisation of Lotus Edge TAVI device
Boston Scientific has...
EuroPCR 2017: Lotus TAVI device has superior efficacy to CoreValve at one year
Data from the REPRISE III...
UK Patents Court makes initial decision on Edwards Sapien 3 and Boston Scientific’s patents
The Patents Court in ...
Locking mechanism problems prompt Boston Scientific to recall all ranges of its Louts TAVI device
According to Reuters,...
TCT 2016: Women and minorities have a significantly higher risk of death after PCI than white men
Data from the PLATINU...
Two-year MAJESTIC data show sustained positive results for Eluvia drug-eluting stent
The MAJESTIC trial set ou...
Boston Scientific issues urgent recall of Lotus systems manufactured prior to March 2016.
Boston Scientific has...
